Delta variant SARS-CoV-2 infections in pediatric cases during the second wave in India
- PMID: 35843834
- PMCID: PMC9250235
- DOI: 10.1016/j.jmii.2022.06.001
Delta variant SARS-CoV-2 infections in pediatric cases during the second wave in India
Abstract
Background: During October 2020, Delta variant was detected for the first time in India and rampantly spread across the globe. It also led to second wave of pandemic in India which affected millions of people. However, there is limited information pertaining to the SARS-CoV-2 strain infecting the children in India.
Methods: Here, we assessed the SARS-CoV-2 lineages circulating in the pediatric population of India during the second wave of the pandemic. Clinical and demographic details linked with the nasopharyngeal/oropharyngeal swabs (NPS/OPS) collected from SARS-CoV-2 cases (n = 583) aged 0-18 year and tested positive by real-time RT-PCR were retrieved from March to June 2021.
Results: Symptoms were reported among 37.2% of patients and 14.8% reported to be hospitalized. The E gene CT value had significant statistical difference at the point of sample collection when compared to that observed in the sequencing laboratory. Out of these 512 sequences 372 were VOCs, 51 were VOIs. Most common lineages observed were Delta, followed by Kappa, Alpha and B.1.36, seen in 65.82%, 9.96%, 6.83% and 4.68%, respectively in the study population.
Conclusion: Overall, it was observed that Delta strain was the leading cause of SARS-CoV-2 infection in Indian children during the second wave of the pandemic. We emphasize on the need of continuous genomic surveillance in SARS-CoV-2 infection even amongst children.
Keywords: COVID-19; Delta variant; India; Pediatric; SARS-CoV-2.
Copyright © 2022. Published by Elsevier B.V.
Conflict of interest statement
Declaration of competing interest The authors declare no conflict of interest.
Figures
References
-
- India COVID: 34,386,786 cases and 461,827 deaths - worldometer [Internet]. [cited 2021 Nov 10]. Available from: https://www.worldometers.info/coronavirus/country/india/.
-
- Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations - SARS-CoV-2 coronavirus/nCoV-2019 Genomic Epidemiology. Virological. 2020 https://virological.org/t/preliminary-genomic-characterisation-of-an-eme... [Internet] [cited 2021 Jun 14]. Available from:
-
- CDC . Centers for Disease Control and Prevention; 2020. Coronavirus Disease 2019 (COVID-19)https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html [Internet] [cited 2021 Nov 10]. Available from:
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
